Cargando…

The landscape of expression and alternative splicing variation across human traits

Understanding the consequences of individual transcriptome variation is fundamental to deciphering human biology and disease. We implement a statistical framework to quantify the contributions of 21 individual traits as drivers of gene expression and alternative splicing variation across 46 human ti...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Pérez, Raquel, Ramirez, Jose Miguel, Ripoll-Cladellas, Aida, Chazarra-Gil, Ruben, Oliveros, Winona, Soldatkina, Oleksandra, Bosio, Mattia, Rognon, Paul Joris, Capella-Gutierrez, Salvador, Calvo, Miquel, Reverter, Ferran, Guigó, Roderic, Aguet, François, Ferreira, Pedro G., Ardlie, Kristin G., Melé, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903719/
https://www.ncbi.nlm.nih.gov/pubmed/36777183
http://dx.doi.org/10.1016/j.xgen.2022.100244
Descripción
Sumario:Understanding the consequences of individual transcriptome variation is fundamental to deciphering human biology and disease. We implement a statistical framework to quantify the contributions of 21 individual traits as drivers of gene expression and alternative splicing variation across 46 human tissues and 781 individuals from the Genotype-Tissue Expression project. We demonstrate that ancestry, sex, age, and BMI make additive and tissue-specific contributions to expression variability, whereas interactions are rare. Variation in splicing is dominated by ancestry and is under genetic control in most tissues, with ribosomal proteins showing a strong enrichment of tissue-shared splicing events. Our analyses reveal a systemic contribution of types 1 and 2 diabetes to tissue transcriptome variation with the strongest signal in the nerve, where histopathology image analysis identifies novel genes related to diabetic neuropathy. Our multi-tissue and multi-trait approach provides an extensive characterization of the main drivers of human transcriptome variation in health and disease.